MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from the
exercise of warrants, net...
$1,934,051
Proceeds from common
stock sold for cash...
$1,058,300
Net cash provided by
financing activities
$2,992,351
Net increase in cash
$907,778
Canceled cashflow
$2,084,573
Stock-based compensation
$186,981
Prepaid expenses and
other current assets
-$84,603
Depreciation expense
$40,369
Net cash used in
operating activities
-$2,074,956
Effect of foreign
exchange rate on changes...
-$9,617
Canceled cashflow
$311,953
Net loss
-$1,873,669
Accounts payable,
accrued expenses and...
-$284,682
Other
-$128,683
Due to related
parties
-$99,875
Back
Back
Cash Flow
source: myfinsight.com
Enveric Biosciences, Inc. (ENVB)
Enveric Biosciences, Inc. (ENVB)